e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reply: BAL lymphocyte percentage is as good as the company it keeps
Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson
Source:
Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
Journal Issue:
February
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson. Reply: BAL lymphocyte percentage is as good as the company it keeps. Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
The impact of anti-IgE treatment on the airway microbiome in asthma.
Does “UIPAF” really exist?
Related content which might interest you:
Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018
Year: 2018
Pulmonary dendritic cells: playing ball in the BAL?
Source: Eur Respir J 2007; 30: 823-824
Year: 2007
Normal values for bronchoalveolar lavage (BAL) differential cell count and lymphocyte subpopulations
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Which CD8+ T-cells in asthma? Attacking or defending?
Source: Eur Respir J 2016; 48: 287-290
Year: 2016
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
BAL cell counts in the diagnosis of lung diseases: is there a gain in information?
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Year: 2002
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Year: 2004
Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
T lymphocyte subsets in bronchoalveolar lavage: A flow cytometric and its importance in the differntial diagnosis of sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 265s
Year: 2003
The meaning of a high monocyte to lymphocyte ratio in tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
COPD treatment choices based on blood eosinophils: are we there yet?
Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019
Year: 2019
T
reg
cells are expanded among bronchoalveolar lymphocytes in healthy tuberculosis contacts with positive interferon-γ release assay responses
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Elevated blood eosinophils in bronchiectasis: A distinct phenotype?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept